DV
Dividend Vision

FHTX — Foghorn Therapeutics Inc

Foghorn Therapeutics Inc (FHTX)

Total return is -65.5% over the past 5.8 years, 208.3 points behind SPY at 142.8%. Its deepest 1-year drawdown was 46.1%.

FHTX is an equity fund focused on Foghorn Therapeutics Inc, a single-stock holding established in October 2020. The fund provides direct exposure to a biopharmaceutical company without a stated dividend distribution strategy, as indicated by its N/A distribution rate and frequency. This fund structure appeals primarily to investors seeking targeted exposure to a specific therapeutic company rather than those pursuing regular dividend income.

FHTX key facts

Asset type
Stock
Asset class
Equity
Inception date
10/23/2020
Last close
$6.26
Market cap
$304,725,248
Average volume
140019.0
Beta
2.862
Payout ratio
0.0
Forward P/E
0.0
EPS
$-1.17